Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073334 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sophie-Charlotte Nelz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Center for Internal Medicine, Rostock University Medical Center, 18057 Rostock, Germany. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Endothelial Cells, Microvessels, Plasma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Damp Stiftung, University of Rostock, “Unsere Besten promovieren in Rostock” of the University of Rostock.
Abstract (Originalsprache)
hiPSC-derived blood–brain barrier (BBB) models are valuable for pharmacological and physiological studies, yet their translational potential is limited due to insufficient cell phenotypes and the neglection of the complex environment of the BBB. This study evaluates the plasma compatibility with hiPSC-derived microvascular endothelial-like cells to enhance the translational potential of in vitro BBB models. Therefore, plasma samples (sodium/lithium heparin, citrate, EDTA) and serum from healthy donors were tested on hiPSC-derived microvascular endothelial-like cells at concentrations of 100%, 75%, and 50%. After 24 h, cell viability parameters were assessed. The impact of heparin-anticoagulated plasmas was further evaluated regarding barrier function and endothelial phenotype of differentiated endothelial-like cells. Finally, sodium-heparin plasma was tested in an isogenic triple-culture BBB model with continuous TEER measurements for 72 h. Only the application of heparin-anticoagulated plasmas did not significantly alter viability parameters compared to medium. Furthermore, heparin plasmas improved barrier function without increasing cell density and induced a von Willebrand factor signal. Finally, continuous TEER measurements of the triple-culture model confirmed the positive impact of sodium-heparin plasma on barrier function. Consequently, heparin-anticoagulated plasmas were proven to be compatible with hiPSC-derived microvascular endothelial-like cells. Thereby, the translational potential of BBB models can be substantially improved in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Center for Internal Medicine, Rostock University Medical Center, 18057 Rostock, Germany.
- Department of Extracorporeal Therapy Systems, Fraunhofer Institute for Cell Therapy and Immunology IZI, 18057 Rostock, Germany.
- Center for Anesthesiology and Intensive Care Medicine, Hospital of Magdeburg, 39130 Magdeburg, Germany.
ORCID-Profile: Sophie-Charlotte Nelz
Förderung
- Damp Stiftung
- University of Rostock
- “Unsere Besten promovieren in Rostock” of the University of Rostock
Zitieren
APA
Nelz, S. C., Lück, E., Schölzel, A., Sauer, M., Heskamp, J., & Doss, S. (2025). Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073334
Vancouver
Nelz SC, Lück E, Schölzel A, Sauer M, Heskamp J, Doss S. Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073334
BibTeX
@article{Nelz2025,
author = {Nelz, Sophie-Charlotte and Lück, Elisabeth and Schölzel, Anne and Sauer, Martin and Heskamp, Jacqueline and Doss, Sandra},
title = {Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073334}
}
EUVIMED